The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 Genitourinary Cancers Symposium ...

The bladder cancer market is poised for transformative growth between 2025 and 2035, driven by rising global incidence rates, ...

The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...

The treatment regimen reduced the risk of developing distant metastases or death due to bladder cancer by 33%.

为解决膀胱癌治疗中 BCG 疗效不佳的问题，石河子大学医学院的研究人员开展了 Mcl-1 下调联合 BCG 治疗膀胱癌的研究。结果显示该联合治疗可促进巨噬细胞极化，提升疗效。这为膀胱癌治疗提供新思路，强烈推荐科研读者阅读。

Among patients with suspected MIBC, the incorporation of mpMRI for initial staging prior to transurethral resection of ...

Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...

The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...

Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of ...

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with nearly 17,000 ...

Using the Decipher Bladder test to determine each tumor’s molecular subtype, researchers found that NMIBC patients with ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...